FDA Inspection 1216202 — Curium US, LLC

Curium US, LLC — FEI 1946929

The FDA completed an inspection of Curium US, LLC on August 18, 2023 in Maryland Heights, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 18, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Maryland Heights, MO (United States)